The World Market for Adrenal Cortical Hormones and Derivatives: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for adrenal cortical hormones and derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for adrenal cortical hormones and derivatives for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Adrenal cortical hormones and derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "adrenal cortical hormones and derivatives" is 54153.
- 1 METHODOLOGY
- 1.1 OUR APPROACH
- 2 THE WORLD MARKET
- 2.1 EXPORTS
- 2.1.1 THE WORLD MARKET: ADRENAL CORTICAL HORMONES AND DERIVATIVES EXPORT SUPPLIES IN 2024
- 2.2 IMPORTS
- 2.2.1 THE WORLD MARKET: IMPORTED ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3 EXPORTS
- 3.1 AFRICA: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.1.1 EXECUTIVE SUMMARY
- 3.1.2 ESWATINI
- 3.2 ASIA: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.2.1 EXECUTIVE SUMMARY
- 3.2.2 CHINA
- 3.2.3 HONG KONG
- 3.2.4 INDIA
- 3.2.5 INDONESIA
- 3.2.6 JAPAN
- 3.2.7 MALAYSIA
- 3.2.8 SINGAPORE
- 3.2.9 SOUTH KOREA
- 3.2.10 TAIWAN
- 3.2.11 THAILAND
- 3.3 EUROPE: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.3.1 EXECUTIVE SUMMARY
- 3.3.2 AUSTRIA
- 3.3.3 BELGIUM
- 3.3.4 BULGARIA
- 3.3.5 CYPRUS
- 3.3.6 DENMARK
- 3.3.7 FINLAND
- 3.3.8 FRANCE
- 3.3.9 GERMANY
- 3.3.10 GREECE
- 3.3.11 HUNGARY
- 3.3.12 IRELAND
- 3.3.13 ITALY
- 3.3.14 LITHUANIA
- 3.3.15 MALTA
- 3.3.16 POLAND
- 3.3.17 PORTUGAL
- 3.3.18 RUSSIA
- 3.3.19 SPAIN
- 3.3.20 SWEDEN
- 3.3.21 SWITZERLAND
- 3.3.22 THE CZECH REPUBLIC
- 3.3.23 THE NETHERLANDS
- 3.3.24 THE UNITED KINGDOM
- 3.4 LATIN AMERICA: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.4.1 EXECUTIVE SUMMARY
- 3.4.2 ARGENTINA
- 3.4.3 BRAZIL
- 3.4.4 COLOMBIA
- 3.4.5 EL SALVADOR
- 3.4.6 MEXICO
- 3.4.7 PANAMA
- 3.4.8 PARAGUAY
- 3.4.9 URUGUAY
- 3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.5.1 EXECUTIVE SUMMARY
- 3.5.2 BERMUDA
- 3.5.3 CANADA
- 3.5.4 THE UNITED STATES
- 3.6 OCEANIA: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.6.1 EXECUTIVE SUMMARY
- 3.6.2 AUSTRALIA
- 3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF ADRENAL CORTICAL HORMONES AND DERIVATIVES IN 2024
- 3.7.1 EXECUTIVE SUMMARY
- 3.7.2 IRAN
- 3.7.3 ISRAEL
- 3.7.4 SAUDI ARABIA
- 3.7.5 TURKEY
- 4 IMPORTS
- 4.1 AFRICA: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.1.1 EXECUTIVE SUMMARY
- 4.1.2 ALGERIA
- 4.1.3 EGYPT
- 4.1.4 MOROCCO
- 4.1.5 NIGERIA
- 4.1.6 SOUTH AFRICA
- 4.1.7 ZIMBABWE
- 4.2 ASIA: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.2.1 EXECUTIVE SUMMARY
- 4.2.2 CHINA
- 4.2.3 HONG KONG
- 4.2.4 INDIA
- 4.2.5 INDONESIA
- 4.2.6 JAPAN
- 4.2.7 MALAYSIA
- 4.2.8 NEPAL
- 4.2.9 SINGAPORE
- 4.2.10 SOUTH KOREA
- 4.2.11 SRI LANKA
- 4.2.12 TAIWAN
- 4.2.13 THAILAND
- 4.2.14 THE PHILIPPINES
- 4.2.15 VIETNAM
- 4.3 EUROPE: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.3.1 EXECUTIVE SUMMARY
- 4.3.2 AUSTRIA
- 4.3.3 BELARUS
- 4.3.4 BELGIUM
- 4.3.5 BULGARIA
- 4.3.6 CROATIA
- 4.3.7 CYPRUS
- 4.3.8 DENMARK
- 4.3.9 FINLAND
- 4.3.10 FRANCE
- 4.3.11 GERMANY
- 4.3.12 GREECE
- 4.3.13 HUNGARY
- 4.3.14 IRELAND
- 4.3.15 ITALY
- 4.3.16 MALTA
- 4.3.17 MOLDOVA
- 4.3.18 POLAND
- 4.3.19 PORTUGAL
- 4.3.20 ROMANIA
- 4.3.21 RUSSIA
- 4.3.22 SLOVAKIA
- 4.3.23 SLOVENIA
- 4.3.24 SPAIN
- 4.3.25 SWEDEN
- 4.3.26 SWITZERLAND
- 4.3.27 THE CZECH REPUBLIC
- 4.3.28 THE NETHERLANDS
- 4.3.29 THE UNITED KINGDOM
- 4.3.30 UKRAINE
- 4.4 LATIN AMERICA: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.4.1 EXECUTIVE SUMMARY
- 4.4.2 ARGENTINA
- 4.4.3 BOLIVIA
- 4.4.4 BRAZIL
- 4.4.5 CHILE
- 4.4.6 COLOMBIA
- 4.4.7 ECUADOR
- 4.4.8 EL SALVADOR
- 4.4.9 GUATEMALA
- 4.4.10 HONDURAS
- 4.4.11 MEXICO
- 4.4.12 NICARAGUA
- 4.4.13 PARAGUAY
- 4.4.14 PERU
- 4.4.15 SURINAME
- 4.4.16 URUGUAY
- 4.5 NORTH AMERICA & THE CARIBBEAN: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.5.1 EXECUTIVE SUMMARY
- 4.5.2 CANADA
- 4.5.3 THE DOMINICAN REPUBLIC
- 4.5.4 THE UNITED STATES
- 4.6 OCEANIA: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.6.1 EXECUTIVE SUMMARY
- 4.6.2 AUSTRALIA
- 4.6.3 NEW ZEALAND
- 4.7 THE MIDDLE EAST: ADRENAL CORTICAL HORMONES AND DERIVATIVES IMPORTS IN 2024
- 4.7.1 EXECUTIVE SUMMARY
- 4.7.2 BAHRAIN
- 4.7.3 ISRAEL
- 4.7.4 JORDAN
- 4.7.5 KUWAIT
- 4.7.6 LEBANON
- 4.7.7 OMAN
- 4.7.8 PAKISTAN
- 4.7.9 QATAR
- 4.7.10 TURKEY
- 5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
- 5.1 DISCLAIMERS & SAFE HARBOR
- 5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook